Laurion Capital Management LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
Codiak BioSciences, Inc. | March 03, 2023 | 3,713,300 | 9.6% |
Pyxis Oncology, Inc. | February 08, 2023 | 3,170,803 | 9.0% |
Research Alliance Corp. II | February 08, 2023 | ? | ? |